Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2026-01-06 @ 9:57 AM
Study NCT ID:
NCT03849456
Status:
TERMINATED
Last Update Posted:
2022-09-02
First Post:
2019-02-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder
Sponsor:
Jazz Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-05-26
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-20
First Submit QC Date:
None
Study First Post Date:
2019-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-05-27
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-08-31
Last Update Post Date:
2022-09-02
Last Update Post Date Type:
ACTUAL